Send the following on WhatsApp
Continue to Chat百濟神州(BeiGene)將於2023年美國臨床腫瘤學會(ASCO)胃腸癌專題研討會上公佈百澤安®(替雷利珠單抗)全球開發項目最新研究進展 https://geneonline.news/%e7%99%be%e6%bf%9f%e7%a5%9e%e5%b7%9e%ef%bc%88beigene%ef%bc%89%e5%b0%87%e6%96%bc2023%e5%b9%b4%e7%be%8e%e5%9c%8b%e8%87%a8%e5%ba%8a%e8%85%ab%e7%98%a4%e5%ad%b8%e6%9c%83%ef%bc%88asco%ef%bc%89%e8%83%83/